Cell-free DNA Analysis of Chromosome Anomalies in Early Pregnancy Loss
NCT04935138 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 78
Last updated 2023-12-01
Summary
The study assesses the accuracy of cell-free DNA (cfDNA) analysis in detecting whole chromosomal aneuploidies from maternal plasma of patients with early, missed miscarriage.
Conditions
- Early Pregnancy Loss
Interventions
- GENETIC
-
cfDNA analysis
sequencing data from cfDNA analysis
Sponsors & Collaborators
-
Illumina, Inc.
collaborator INDUSTRY -
Quest Diagnostics-Nichols Insitute
lead INDUSTRY
Principal Investigators
-
Pranoot X Tanpaiboon, MD · Quest Diagnostics-Nichols Insitute
-
Karen E Racicot, PhD · Quest Diagnostics-Nichols Insitute
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-01
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
Countries
- United States
Study Locations
More Related Trials
-
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
NCT01404221 ·Status: TERMINATED
-
"Circulating Fetal DNA, Pregnancy And Immune Diseases"
NCT04155086 ·Status: UNKNOWN ·Phase: NA
-
First Trimester Risk Assessment Based on Ultrasound and Cell-free DNA vs Combined Screening
NCT04077060 ·Status: COMPLETED ·Phase: NA
-
Genomic Sequencing in Anatomically Normal Fetuses
NCT06211348 ·Status: RECRUITING ·Phase: NA
-
Antenatal Detection by Array CGH Genomic Rearrangements Unbalanced Front Uninsulated Thick Neck or a Combination of Two Signs of Ultrasound Calling Normal Karyotype
NCT03239002 ·Status: COMPLETED
-
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00971334 ·Status: COMPLETED
-
Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis
NCT01279733 ·Status: COMPLETED
-
Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
NCT04232189 ·Status: TERMINATED
-
Comparison of Aneuploidy Risk Evaluations
NCT01663350 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening
NCT02991729 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852 ·Status: UNKNOWN
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Embryo Health Study
NCT04528498 ·Status: RECRUITING
-
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 ·Status: COMPLETED
-
NIPD of CFTC by WGA Coupled to Mini-exome Sequencing
NCT03743948 ·Status: UNKNOWN ·Phase: NA
-
Comprehensive Assessment of Risks for Miscarriage.
NCT04456660 ·Status: RECRUITING
-
A Follow-up of the Early Pregnancy Study Cohort.
NCT01132924 ·Status: COMPLETED
-
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
NCT06523543 ·Status: RECRUITING
-
Realization of Sequencing of All Known Human Genes in Case of Detection of Cerebral, Renal or Ophthalmological Fetal Malformations During Pregnancy in Order to Make an Etiological Diagnosis and to Precise the Fetal Prognosis
NCT04406480 ·Status: UNKNOWN ·Phase: NA
-
High Risk Multiple Gestation Study
NCT02278874 ·Status: COMPLETED
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta
NCT01279369 ·Status: TERMINATED
-
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis
NCT02255825 ·Status: WITHDRAWN ·Phase: NA
-
Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies
NCT05004337 ·Status: COMPLETED